A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma.

Abstract:

:Long non-coding RNAs (lncRNAs) have been considered as biomarkers for the carcinogenesis and development of various cancers. However, the prognostic significance of lncRNAs in renal cell carcinoma (RCC) remains unclear. This study aimed to determine the predictive ability of lncRNAs in clear cell RCC (ccRCC). Among the cohort of kidney renal clear cell carcinoma (KIRC) of the The Cancer Genome Atlas (TCGA), 525 patients were enrolled in our study. Expression of lncRNAs based on RNAseq was obtained from TCGA. Kaplan-Meier prognostic analysis and a Cox proportional hazards regression model were used to assess related factors. The lncRNA signature was then validated in an independent cohort of an additional 60 ccRCC patients. Hierarchical clustering of the KIRC TCGA dataset identified 26 differentially expressed lncRNAs (11 down-regulated and 15 up-regulated) using average linkage clustering. Kaplan-Meier survival analysis identified 30 statistically significant lncRNAs that strongly predicted prognosis, with 4 ccRCC-specific lncRNAs (TCL6, PVT1, MIR155HG, and HAR1B) being differentially expressed and correlating significantly with OS. Patients assigned to the high-risk group were associated with poor OS compared with patients in the low-risk group (HR = 2.57; 95%CI, 1.89-3.50; p < 0.001). This finding was validated in the Tongji Hospital cohort, and the four-lncRNA signature was shown to be significantly predictive of ccRCC prognosis (p < 0.001). In this study, we constructed an applicable four-lncRNA-based classifier as a reliable prognostic and predictive tool for OS in patients with ccRCC.

journal_name

J Cancer

journal_title

Journal of Cancer

authors

Liu H,Ye T,Yang X,Lv P,Wu X,Zhou H,Zeng J,Tang K,Ye Z

doi

10.7150/jca.40421

subject

Has Abstract

pub_date

2020-04-27 00:00:00

pages

4274-4283

issue

14

issn

1837-9664

pii

jcav11p4274

journal_volume

11

pub_type

杂志文章
  • Incidence and Impact of Lymph Node Metastases in Advanced Ovarian Cancer: Implications for Surgical Treatment.

    abstract::Background: This study aimed to clarify the impact of node involvement (affected to resected nodes) in optimally cytoreduced (residual tumour ≤1cm) stage IIIC/IV ovarian cancer. Methods: 108 consecutive patients with primary stage IIIC/IV ovarian cancer underwent stage-related surgery and got adjuvant platinum-based c...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.15644

    authors: Bachmann C,Bachmann R,Fend F,Wallwiener D

    更新日期:2016-11-09 00:00:00

  • Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients.

    abstract:PURPOSE:Chemotherapy regimens containing anthracyclines and taxanes represent the landmark of neoadjuvant systemic therapy of breast cancer. In advanced breast cancer patients liposomal anthracyclines (LA) have shown similar efficacy and less cardiac toxicity when compared to conventional anthracyclines. We performed t...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.9132

    authors: Vici P,Pizzuti L,Gamucci T,Sergi D,Conti F,Zampa G,Del Medico P,De Vita R,Pozzi M,Botti C,Di Filippo S,Tomao F,Sperduti I,Di Lauro L

    更新日期:2014-04-25 00:00:00

  • Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model.

    abstract::Chemo- and radio-therapy suffer from certain well-recognized drawbacks for lymphoma therapy. Passive immunotherapy with monoclonal antibody has improved outcome for patients with CD20+ B cell lymphoma, but not for T cell lymphoma. Therefore, novel treatment approaches are clearly required for T cell lymphoma. To date,...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.20015

    authors: Gao D,Li W,Wang W,Cai Y,Wang Y,Luo X,Wei CC

    更新日期:2017-09-15 00:00:00

  • Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent.

    abstract::The hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) with its immunotherapeutic activities and sialic acid binding abilities is a promising cancer adjuvant. The HN was surfaced displayed on Lactococcus lactis and its cancer targeting ability was investigated via attachment to the MDA-MB231 bre...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.13566

    authors: Baradaran A,Yusoff K,Shafee N,Rahim RA

    更新日期:2016-01-29 00:00:00

  • Diagnostic accuracy of frozen section analysis of borderline ovarian tumors: a meta-analysis with emphasis on misdiagnosis factors.

    abstract::Objective: First, to evaluate the sensitivity and positive predictive value (PPV) of intra-operative frozen section (FS) diagnosis in borderline ovarian tumors (BOTs), and to explore the factors affecting the diagnostic accuracy. Second, to assess the clinical outcomes of misdiagnosed BOT patients. Methods: We perform...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.25883

    authors: Huang Z,Li L,Li C,Ngaujah S,Yao S,Chu R,Xie L,Yang X,Zhang X,Liu P,Jiang J,Zhang Y,Cui B,Song K,Kong B

    更新日期:2018-07-16 00:00:00

  • Latest Overview of the Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: The Past, the Present and the Future.

    abstract::Endocrine resistance in hormone receptor positive breast cancer patients urges us to develop novel approaches such as inhibitors of the cyclin-dependent kinases (CDK) 4/6 to reverse its resistance. Nowadays, three selective CDK4/6 inhibitors (Palbociclib, Ribociclib and Abemaciclib) are approved by Federal Drug Admini...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.33079

    authors: Chen X,Xu D,Li X,Zhang J,Xu W,Hou J,Zhang W,Tang J

    更新日期:2019-10-21 00:00:00

  • Effects of MACC1 polymorphisms on hepatocellular carcinoma development and clinical characteristics.

    abstract::Hepatocellular carcinoma (HCC) is a major malignancy of cancer-related mortality worldwide. Metastasis-associated in colon cancer-1 (MACC1) was suggested as a marker for vascular invasive HCC. This study investigated the MACC1 single-nucleotide polymorphisms (SNPs) to evaluate HCC susceptibility and clinicopathologica...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.38856

    authors: Lin CH,Hsieh MJ,Lee HL,Yang SF,Su SC,Lee WJ,Chou YE

    更新日期:2020-01-14 00:00:00

  • Improved Long-Term Clinical Outcomes And Safety Profile Of Sunitinib Dosing Schedule With 4/2 Switched To 2/1 In Patients With Metastatic Renal Cell Carcinoma.

    abstract::Purpose: This study aimed to identify the survival benefit and safety of alternative dosage schedules for sunitinib in metastatic renal cell carcinoma. Materials and Methods: Clinicopathologic and survival data of patients treated with sunitinib as first-line therapy were retrospectively reviewed. Patients were classi...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.25693

    authors: Zhang X,Sun G,Zhao J,Shu K,Zhao P,Liu J,Yang Y,Tang Q,Chen J,Shen P,Wang J,Zeng H

    更新日期:2018-09-07 00:00:00

  • Can Patients with Pancreatic Cancer and Liver Metastases Obtain Survival Benefit from Surgery? A Population-Based Study.

    abstract::Background: Surgery for pancreatic cancer with liver metastases (PCL) is not recommended in the international guidelines, and investigation of its clinical significance in patients with PCL is very limited. This study explored whether surgery, especially synchronous resection of the primary tumor and liver metastases ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.51218

    authors: Su BB,Bai DS,Yu JQ,Zhang C,Jin SJ,Zhou BH,Jiang GQ

    更新日期:2021-01-01 00:00:00

  • High Expression of PQBP1 and Low Expression of PCK2 are Associated with Metastasis and Recurrence of Osteosarcoma and Unfavorable Survival Outcomes of the Patients.

    abstract::Osteosarcoma (OS) is the most common primary bone malignancy, predominately affecting children and adolescents. Due to the introduction of chemotherapy, the 5-year survival rate of OS patients has dramatically improved to 60-70%. Unfortunately, OS patients with recurrence or metastatic disease have less than a 20% cha...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.28480

    authors: Zhang Y,Zhao H,Xu W,Jiang D,Huang L,Li L

    更新日期:2019-05-12 00:00:00

  • Carbonic Anhydrase 4 serves as a Clinicopathological Biomarker for Outcomes and Immune Infiltration in Renal Cell Carcinoma, Lower Grade Glioma, Lung Adenocarcinoma and Uveal Melanoma.

    abstract::Background: Carbonic anhydrase 4 (CA4) maintains homeostasis of carbon dioxide and bicarbonate. It is suggested to be a potential prognostic biomarker, while the correlations between CA4 and different cancers are indistinct. Methods: Differential mRNA expression of CA4 among different cancers and corresponding normal ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.46902

    authors: Xu Y,Xu WH,Shi SN,Yang XL,Ren YR,Zhuang XY,Qu YY,Zhang HL,Zhang XF

    更新日期:2020-08-25 00:00:00

  • Advances in biophotonics detection of field carcinogenesis for colon cancer risk stratification.

    abstract::The process of neoplastic transformation of the colon involves a progression through hyperproliferative epithelium through the aberrant crypt foci→small adenoma→large adenoma→invasive cancer→metastatic disease. These are orchestrated by sequential genetic and epigenetic events which provide the underpinnings of cellul...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.5838

    authors: Backman V,Roy HK

    更新日期:2013-01-01 00:00:00

  • The Kinetic Changes of Systemic Inflammatory Factors during Bevacizumab Treatment and Its Prognostic Role in Advanced Non-small Cell Lung Cancer Patients.

    abstract::Background: Bevacizumab combined with chemotherapy is still one of the standard options for treatment of advanced non-small cell lung cancer (NSCLC) patients without driver mutations. Serum inflammatory factors, representing the systemic immune status, are shown to have complicated relationships with tumor angiogenesi...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.30478

    authors: Li B,Wang S,Li C,Guo M,Xu Y,Sun X,Yu J,Wang L

    更新日期:2019-08-28 00:00:00

  • Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients.

    abstract::Purpose: Diffuse large B cell lymphoma (DLBCL) is one of the most common B cell lymphomas, which displays heterogeneous pathologies. Programmed cell death 1/ programmed cell death ligand 1 (PD-1/PD-L1) plays an essential role in immunosuppression in multiple malignancies. Signal transducer and activator of transcripti...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.47816

    authors: Fei Y,Yu J,Li Y,Li L,Zhou S,Zhang T,Li L,Qiu L,Meng B,Pan Y,Ren X,Qian Z,Wang X,Zhang H

    更新日期:2020-10-17 00:00:00

  • BCR-ABL1 transcript decline ratio combined BCR-ABL1IS as a precise predictor for imatinib response and outcome in the patients with chronic myeloid leukemia.

    abstract::Purpose: The early BCR-ABL1 reduction had the prognostic impact of the chronic-phase chronic myeloid leukemia (CML-CP) patients. This study was to find a more precise early prognosis index at 3 months in the patients with newly diagnosed CML-CP, especially for the patients with BCR-ABL1IS >10%. Methods: We retrospecti...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.38752

    authors: Cai Z,Jia X,Zi J,Song H,Wang S,McGrath M,Zhao L,Song C,Ge Z

    更新日期:2020-02-03 00:00:00

  • VEGFR-2 Inhibitor Apatinib Hinders Endothelial Cells Progression Triggered by Irradiated Gastric Cancer Cells-derived Exosomes.

    abstract::Background: Radiotherapy is a standard treatment for a significant fraction of cancer patients. Nonetheless, to this day radiation resistance is a key impediment in gastric cancer (GC) treatment. Moreover, GC is characterized by its substantial neo-angiogenesis, driven by high levels of vascular endothelial growth fac...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.25370

    authors: Li G,Lin H,Tian R,Zhao P,Huang Y,Pang X,Zhao L,Cao B

    更新日期:2018-10-18 00:00:00

  • Factors Influencing Adjuvant Chemotherapy and Trastuzumab Choice in Older Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Patients.

    abstract::Objectives: This study aims to evaluate influence factors for adjuvant chemotherapy regimen choice on the basis of trastuzumab in older human epidermal growth factor receptor 2 (HER2)-positive breast cancer under multi-disciplinary team (MDT) modality. Materials and Methods: HER2-positive breast cancer patients aged ≥...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.39509

    authors: Fang Y,Wang Z,Wu J,Huang O,He J,Zhu L,Chen W,Li Y,Chen X,Shen K

    更新日期:2020-02-14 00:00:00

  • Radiomic Nomogram: Pretreatment Evaluation of Local Recurrence in Nasopharyngeal Carcinoma based on MR Imaging.

    abstract::Background: To develop and validate a radiomic nomogram incorporating radiomic features with clinical variables for individual local recurrence risk assessment in nasopharyngeal carcinoma (NPC) patients before initial treatment. Methods: One hundred and forty patients were randomly divided into a training cohort (n = ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.33345

    authors: Zhang L,Zhou H,Gu D,Tian J,Zhang B,Dong D,Mo X,Liu J,Luo X,Pei S,Dong Y,Huang W,Chen Q,Liang C,Lian Z,Zhang S

    更新日期:2019-07-10 00:00:00

  • Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer.

    abstract::The purpose of this study was to determine the association between body mass index (BMI) measurements (baseline BMI and changes in BMI during neoadjuvant systemic treatment [NST]) and clinical efficacy (pathologic complete response [pCR] rate and survival outcomes) in locally advanced breast cancer (LABC). We hypothes...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.10580

    authors: Kogawa T,Fouad TM,Wei C,Masuda H,Kai K,Fujii T,El-Zein R,Chavez-MacGregor M,Litton JK,Brewster A,Alvarez RH,Hortobagyi GN,Valero V,Theriault R,Ueno NT

    更新日期:2015-01-22 00:00:00

  • New Prospect for Cancer Cachexia: Medical Cannabinoid.

    abstract::Cachexia is a common term for the wasting symptoms which may appear in almost every chronic illness, such as AIDS, tuberculosis, and cancer. Cancer cachexia (CCA) is a result of the interaction between the host and the tumor, mainly manifested in short-term wasting, malnutrition, and so on. Due to the chronic food sho...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.28246

    authors: Wang J,Wang Y,Tong M,Pan H,Li D

    更新日期:2019-01-01 00:00:00

  • Warburg Effect - a Consequence or the Cause of Carcinogenesis?

    abstract::Ever since its discovery (1924) the Warburg effect (aerobic glycolysis) remains an unresolved puzzle: why the aggressive cancer cells "prefer" to use the energetically highly inefficient method of burning the glucose at the cellular level? While in the course of the last 90 years several hypotheses have been suggested...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.14274

    authors: Devic S

    更新日期:2016-04-26 00:00:00

  • Pancreatic cancer-derived exosomes promoted pancreatic stellate cells recruitment by pancreatic cancer.

    abstract::Cancer-associated fibroblasts (CAFs), which are an important component of the tumor microenvironment, have been identified in the blood circulation of patients with cancer metastasis, and metastatic cancer cells can recruit circulating CAFs. However, primary carcinoma sites usually regulate the behavior of metastatic ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.27590

    authors: Zhang YF,Zhou YZ,Zhang B,Huang SF,Li PP,He XM,Cao GD,Kang MX,Dong X,Wu YL

    更新日期:2019-07-23 00:00:00

  • Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.

    abstract:BACKGROUND:Due to the lack of studies, it remains unclear whether the additional neoadjuvant chemotherapy (NACT) to concurrent chemoradiotherapy (CCRT) is superior to CCRT alone for locoregionally advanced nasopharyngeal carcinoma (NPC). The main objective of this Bayesian network meta-analysis was to determine the eff...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.11814

    authors: Chen YP,Guo R,Liu N,Liu X,Mao YP,Tang LL,Zhou GQ,Lin AH,Sun Y,Ma J

    更新日期:2015-07-17 00:00:00

  • Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067.

    abstract::Objectives: Chordomas are slow-growing malignancies that commonly affect vital neurological structures. These neoplasms are highly resistant to current chemotherapeutic regimens and often recur after surgical intervention. Therefore, there is an urgent need to identify molecular targets and more robust drugs to improv...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.35426

    authors: Shen S,Dean DC,Yu Z,Hornicek F,Kan Q,Duan Z

    更新日期:2020-01-01 00:00:00

  • Statistics and pitfalls of trend analysis in cancer research: a review focused on statistical packages.

    abstract::Trend analysis is the analysis using statistical models to estimate and predict potential trends over time, space or any independent continuous-variable. It has been widely used in epidemiology and public health, but much less so in clinical oncology and basic cancer research. Methodological imitations of the chosen s...

    journal_title:Journal of Cancer

    pub_type: 杂志文章,评审

    doi:10.7150/jca.43521

    authors: Xu J,Lin Y,Yang M,Zhang L

    更新日期:2020-03-04 00:00:00

  • Increased Prevalence of Esophageal Cancer in Areas with High Levels of Nickel in Farm Soils.

    abstract::Background: Heavy metal pollution in farm soils is a grave concern in Taiwan. Previously, we found the incidence of oral cancer (OC) correlated positively with levels of nickel and arsenic in farm soils. Many OC patients have a second malignancy, among which esophageal cancer (EC) is the most common one in Taiwan. Obj...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.15441

    authors: Lee CP,Lee YH,Lian IB,Su CC

    更新日期:2016-08-06 00:00:00

  • Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis.

    abstract::Background: The use of PCI in early operable patients with small cell lung cancer (SCLC) is still controversial. Therefore, we conducted a systematic review with meta-analysis to investigate the effects of PCI in resected SCLC patients. Methods: Relevant studies were identified from PubMed and EMBASE databases, the po...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.21465

    authors: Yang Y,Zhang D,Zhou X,Bao W,Ji Y,Sheng L,Cheng L,Chen Y,Du X,Qiu G

    更新日期:2018-01-01 00:00:00

  • The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1+/- lymphoblastoid cells.

    abstract::The use of polyADPribose polymerase inhibitors in cancer treatment provides a unique opportunity to target DNA repair processes in cancer cells while leaving normal tissue intact. The PARP-1 enzyme repairs DNA single strand breaks (SSB). Therefore PARP-1 inhibition in BRCA1 negative cancers results in the formation of...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.21338

    authors: Bourton EC,Ahorner PA,Plowman PN,Zahir SA,Al-Ali H,Parris CN

    更新日期:2017-10-23 00:00:00

  • Impact Of Circulating T Helper 1 And 17 Cells in the Blood on Regional Lymph Node Invasion in Colorectal Cancer.

    abstract::We hypothesised that the blood levels of immune cells would be related to the progression of colorectal cancer and regional lymph node metastasis. We investigated the association between the blood levels of immune cells and regional lymph node metastasis in colorectal cancer patients. Patients with American Joint Comm...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.18230

    authors: Lee JY,Seo EH,Oh CS,Paik JH,Hwang DY,Lee SH,Kim SH

    更新日期:2017-05-10 00:00:00

  • The combination of PKM2 overexpression and M2 macrophages infiltration confers a poor prognosis for PDAC patients.

    abstract::Macrophages play a critical role in the initiation and progression in various human solid tumors; however, their role and transformation in pancreatic ductal adenocarcinoma (PDAC) were still illusive. Here, immunohistochemistry was used to determine CD206 (specific marker of M2 macrophage) and PKM2 expression in PDAC ...

    journal_title:Journal of Cancer

    pub_type: 杂志文章

    doi:10.7150/jca.38981

    authors: Hu H,Tu W,Chen Y,Zhu M,Jin H,Huang T,Zou Z,Xia Q

    更新日期:2020-02-03 00:00:00